Replying to
@nomadic_m:Thanks for sharing đ Happy weekend đĽ//
@nomadic_m:Jiuyuan Gene (02566) opened its subscription from November 20 to 25. This Chinese biopharmaceutical company plans to issue 45,399,000 H shares, with 10% being publicly offered in Hong Kong. The subscription price range is set between HK$11.48 and HK$12.56, with a maximum fundraising amount of HK$570 million.
HKEX Stocks Opportunities
Any thoughts and experiences on investing in the HK stock market? Share them with all Tigers here!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments